IL-17A+, IL-22+, and IL-23+ immunoreactive cells are increased in bronchial biopsies of patients with stable COPD compared to control subjects (Di Stefano et al., 2009). The gene discussed is IL22; the disease is chronic obstructive pulmonary disease.